David J. McConkey, PhD, on the responses to immunotherapy for varied bladder cancer subtypes OBRoncology 1:00 7 years ago 34 Скачать Далее
David J. McConkey, PhD, on the influence of genomics for the treatment of bladder cancer subtypes OBRoncology 0:25 7 years ago 60 Скачать Далее
David J. McConkey, PhD, on treating bladder cancer with checkpoint inhibitors OBRoncology 1:01 7 years ago 27 Скачать Далее
David J. McConkey, PhD, on non-invasive imaging and monitoring metastatic bladder cancer OBRoncology 0:39 7 years ago 22 Скачать Далее
David J. McConkey, PhD, discusses how genomics helps us understand heterogeneity in bladder cancer OBRoncology 1:59 7 years ago 44 Скачать Далее
David J. McConkey, PhD, on which drugs have the highest potential to impact bladder cancer treatment OBRoncology 1:05 7 years ago 32 Скачать Далее
How can we improve responses to immunotherapy in patients with bladder cancer? VJOncology 1:21 2 years ago 205 Скачать Далее
Predicting Which Bladder Cancer Patients Will Respond to Immunotherapy Breakthroughs for Physicians 10:16 1 year ago 186 Скачать Далее
Dr Li on the Clinical Implications of a Post Hoc Analysis of KEYNOTE-057 in BCG-Unresponsive NMIBC OncLive 1:16 1 day ago 24 Скачать Далее
A Therapeutic Revolution: Immunotherapy for Bladder Cancer OncLive 2:50 6 years ago 373 Скачать Далее
Dr. Galsky Discusses Neoadjuvant Immunotherapy in Bladder Cancer OncLive 1:36 6 years ago 89 Скачать Далее
Navigating Clinical Trials in Bladder Cancer Johns Hopkins Medicine 1:17:24 6 years ago 470 Скачать Далее
